๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wenzhou
Clinical trial register · China

Clinical Trials in Wenzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University32 First Affiliated Hospital of Wenzhou Medical University27 The Eye Hospital of Wenzhou Medical University9 Janssen Research & Development, LLC5 Wenzhou Medical University5
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Wenzhou

184 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis
NCT07466511Idiopathic Scoliosis
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2027-01-01
Not yet open
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
NCT07815301Obstructive Hypertrophic Cardiomyopathy (oHCM)
First Affiliated Hospital of Wenzhou Medical University
Not applicable
286
Wenzhou
2026-12
Not yet open
Toripalimab ยฑ Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase 2
106
Wenzhou
2026-12
Not yet open
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
NCT07827521Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer, Infrapopliteal Arterial Occlusive Disease
First Affiliated Hospital of Wenzhou Medical University
Phase 4
180
Hangzhou, Taizhou, Wenzhou
2026-10-20
Not yet open
Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence
NCT07831187Glioblastoma
First Affiliated Hospital of Wenzhou Medical University
Phase 1/2
96
Wenzhou
2026-10-01
Not yet open
Safety and Efficacy Evaluation of Single-Port Versus Multi-Port Robotic-Assisted Radical Distal Gastrectomy for Gastric Cancer
NCT07828899STOMACH NEOPLASM, Robotic Surgical Procedures
First Affiliated Hospital of Wenzhou Medical University
Not applicable
212
Shijiazhuang, Jinan, Wenzhou, Beijing, Chongqing
2026-10
Not yet open
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
NCT07394205Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1
18
Wenzhou
2026-09-30
Not yet open
AI-Assisted Patient Support in mHSPC
NCT07804030Metastatic Prostate Cancer
Fudan University
Not applicable
160
Fuzhou, Shanghai, Kunming, Wenzhou
2026-09
Not yet open
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
NCT06970496Relapsed or Refractory B Cell Non Hodgkin Lymphoma
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
48
Guangzhou, Nanchang, Shanghai, Wenzhou, Xi'an
2026-08-31
Not yet open
Pharmacokinetics of Huperzine A Oral Solution in Healthy Participants
NCT07784335Healhty
Wanbangde Pharmaceutical Group Co., LTD
Phase 1
40
Wenzhou
2026-08-25
Not yet open
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults
NCT07746726Neuromuscular Blockade
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
320
Changsha, Wenzhou
2026-08-20
Not yet open
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
NCT07775300Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08
Recruiting
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis
NCT07726888Ulcerative Colitis (Disorder), Guselkumab
Second Affiliated Hospital of Wenzhou Medical University
Observational
97
Wenzhou
2026-07-31
Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420NMOSD, Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
A Study of HLX18 vs. OPDIVOยฎ in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Recruiting
Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
NCT07692841Healthy Hematopoietic Stem Cell Donor, Healthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University
Phase 3
560
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
Safety and Efficacy of Eculizumab in High-risk TA-TMA
NCT07707687Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University
Phase 2
24
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports
NCT07707232Prostate Cancer
First Affiliated Hospital of Wenzhou Medical University
Observational
4,600
Wenzhou
2026-06-17
Not yet open
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
NCT07613437Intracerebral Hemorrhage
Chinese University of Hong Kong
Phase 2
200
Hefei, Wenzhou
2026-06-15
Recruiting
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
NCT07692165Ulcerative Colitis (UC)
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Recruiting
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study
NCT07652489Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
70
Harbin, Changsha, Shenyang, Shanghai, Xiโ€™an, Wenzhou
2026-06-01
Recruiting
Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa
NCT07489573Hidradenitis Suppurativa (HS)
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Shijiazhuang, Chengdu, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2026-06-01
Not yet open
Edaravone Dexborneol for Post-Stroke Epilepsy
NCT07604350Post-stroke Epilepsy, Post-stroke Seizure
First Affiliated Hospital of Wenzhou Medical University
Phase 3
160
Wenzhou
2026-06
Not yet open
24-Week Recurrence Rate of Gout Following Firsekibart Treatment
NCT07625514Gout Flare
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
264
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-07
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
NCT07483073Colitis, Ulcerative, Crohn Disease
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Not yet open
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial
NCT07616531Gout Flares
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
118
Hangzhou, Fuzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-01
Recruiting
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
NCT07381634Hepatocellular Carcinoma (HCC), IrAE
First Affiliated Hospital of Wenzhou Medical University
Phase 2
134
Wenzhou
2026-04-30
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3
736
Changsha, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Wenzhou, Wuhan
2026-04-22
Not yet open
Perioperative Pharmacokinetics of Anesthetic Drugs and Complications in Overweight and Obese Patients
NCT07530848Obesity, Overweight
Second Affiliated Hospital of Wenzhou Medical University
Observational
2,100
Wenzhou
2026-04-10
Not yet open
Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
NCT07530133Indications for Laparoscopic Thoracic and Abdominal Surgery in Children, Congenital or Acquired Surgical Conditions Requiring Minimally Invasive Surgery in Children, Pyeloplasty, Ureteral Reimplantation
Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
Not applicable
64
Wuhan, Hangzhou, Wenzhou
2026-04-09
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Not yet open
Effect of High-Flow Nasal Cannula Oxygen Therapy on Hypoxemia in Pediatric Sedated Bronchoscopy
NCT07563075Hypoxemia, Pneumonia, Pulmonary Neoplasm
Zhejiang University
Not applicable
430
Hangzhou, Wenzhou, Chongqing
2026-04-01
Recruiting
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
NCT07495735HCC - Hepatocellular Carcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
Observational
400
Wenzhou
2026-03-22
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Active, closed
A Real-World Exploratory Study on the Sleep-Improving Efficacy of Dong'e Brand Ejiao Yuanjiang
NCT07677709Sleeping Efficacy, Sleep Quality
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
66
Wenzhou
2026-03-06
Not yet open
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children
NCT07424040Crohn's Diseases, Crohn's Disease in Pediatric Patient
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
154
Kunming, Hangzhou, Jinhua, Wenzhou
2026-03-01
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511Multiple Myeloma
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
NCT07276958Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT07347600Locally Advanced Breast Cancer, Metastatic Breast Cancer
Hoffmann-La Roche
Observational
500
Xiamen, Lanzhou, Changchun, Wenzhou, Beijing, Chengdu, Chongqing, Guangzhou
2026-01-21
Recruiting
The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients
NCT03116490Postoperative Complications, Postoperative Mortality
Wenzhou Medical University
Observational
600
Wenzhou
2026-01-16
Not yet open
Intelligent Precision Knee Preservation System for Knee Osteoarthritis
NCT07284524Knee Osteoarthritis (Knee OA)
First Affiliated Hospital of Wenzhou Medical University
Not applicable
150
Wenzhou
2026-01-01
Not yet open
Stereotactic Aspiration of Brain Stem Hematoma
NCT07300501Brain Stem Hematoma
First Affiliated Hospital of Zhejiang University
Not applicable
300
Hangzhou, Changsha, Guangzhou, Jinan, Shanghai, Shenzhen, Taizhou, Wenzhou
2026-01-01
Recruiting
Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
NCT07604896Alzheimer s Disease, Alzheimer Dementia (AD), MCI-AD, Early Stage Alzheimer's Disease
First Affiliated Hospital of Wenzhou Medical University
Phase 4
200
Wenzhou
2026-01-01
Not yet open
Short-term gluCOCOrticoid in Adult STEROID-sensitive Nephrotic Syndrome: The COCO-ASTEROID Study
NCT07151456Idiopathic Nephrotic Syndrome
First Affiliated Hospital of Wenzhou Medical University
Phase 4
224
Wenzhou
2026-01
Recruiting
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT07244341Metastatic Castration-resistant Prostate Cancer
Daiichi Sankyo
Phase 1
60
Guangzhou, Shanghai, Wenzhou
2025-12-03
Active, closed
A Study of DII235 in Adults With Elevated Lipoprotein(a)
NCT07235046Lipoprotein Disorder
Novartis Pharmaceuticals
Phase 2
234
Luoyang, Shenyang, Wenzhou, Beijing
2025-12-02
Recruiting
A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer
NCT07347951Locally Advanced Rectal Cancer (LARC)
First Affiliated Hospital of Wenzhou Medical University
Phase 2
30
Wenzhou
2025-12-01
Not yet open
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
NCT07254858HR+/HER2- Breast Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase 2
302
Wenzhou
2025-12
Recruiting
Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial
NCT07586384Stomach Neoplasms, Robotic Surgical Procedures
First Affiliated Hospital of Wenzhou Medical University
Not applicable
90
Wenzhou
2025-11-05
Active, closed
Mechanism Study of G Protein-coupled Receptor 81 in Multiple Organ Dysfunction of Heat Stroke
NCT07346443Heat Stroke
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2025-11-01
Recruiting
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
NCT07569653Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
WeiShi
Phase 4
120
Beijing, Shijiazhuang, Zhengzhou, Jingzhou, Wuhan, Hohhot, Nanchang, Wenzhou
2025-10-30
Recruiting
Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis
NCT07250269Relapsed/Refractory AL Amyloidosis
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
9
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
NCT07775820Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis
Nanfang Hospital, Southern Medical University
Observational
150
Guangzhou, Shenzhen, Nanchang, Wenzhou
2025-10-20
Recruiting
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
NCT07095075Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Phase EARLY_PHASE1
36
Bengbu, Hefei, Nanjing, Suzhou, Wenzhou
2025-10-14
Recruiting
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
NCT07102628Acute Coronary Syndrome
Novartis Pharmaceuticals
Phase 3
300
Beijing, Guangzhou, Luoyang, Xuzhou, Nanchang, Wenzhou, Fuzhou, Jining
2025-10-03
Recruiting
SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety
NCT07174947Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders, Depression Disorders
First Affiliated Hospital of Wenzhou Medical University
Phase 2
240
Wenzhou
2025-10-01
Not yet open
Preoperative vs Postoperative Revascularization in Coronary Heart Disease Patients Undergoing Time-Sensitive Non-Cardiac Surgery (CHRONOS-PCI)
NCT07175870Coronary Artery Disease, Noncardiac Surgery
First Affiliated Hospital of Wenzhou Medical University
Not applicable
140
Wenzhou
2025-10
Recruiting
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
NCT07198386NASH
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
NCT06919965Non-Muscle Invasive Bladder Neoplasms
Janssen Research & Development, LLC
Phase 3
220
Beijing, Chengdu, Guangzhou, Nanjing, Ningbo, Tianjin, Wenzhou, Wuhan
2025-09-10
Recruiting
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
NCT07193277Focal Epilepsy, Cognitive Impairment
First Affiliated Hospital of Wenzhou Medical University
Phase 4
220
Wenzhou
2025-09-01
Not yet open
Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients
NCT06796660Renal Insufficiency, Chronic
Liu Zhanghong
Phase EARLY_PHASE1
70
Hangzhou, Wenzhou
2025-09-01
Recruiting
Electroacupuncture and rTMS for Post-Stroke Motor Recovery
NCT07113990Stroke
Jing Tao
Not applicable
180
Fuzhou, Wenzhou
2025-08-27
Recruiting
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
NCT07095023Breast Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
112
Beijing, Guangzhou, Shantou, Nanning, Guiyang, Haikou, Wenzhou, Shenzhen
2025-08-15
Not yet open
29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236Primary Hepatocellular Carcinoma
Junjie Xu
Observational
350
Hefei, Chaoyang, Fuzhou, Guangzhou, Zhengzhou, Shanghai, Hangzhou, Wenzhou
2025-08-01
Recruiting
a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease๏ผˆNAFLD๏ผ‰
NCT07128797NAFLD (Non-alcoholic Fatty Liver Disease), NASH (Nonalcoholic Steatohepatitis)
Tasly Biopharmaceuticals Co., Ltd.
Phase 1
32
Beijing, Guangzhou, Datong, Tianjin, Wenzhou
2025-07-24
Recruiting
Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life
NCT07193329Psychological Distress, Malignant Tumor
Gang Chen, MD
Observational
2,000
Wenzhou
2025-07-22
Recruiting
Effect of Adenotonsillectomy on Spinal Curve Magnitude in Children With Sleep-Disordered Breathing
NCT07332780Sleep-disordered Breathing (SDB), Idiopathic Scoliosis, Obstructive Sleep Apnea (OSA)
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
160
Wenzhou
2025-07-11
Active, closed
The A.R.R.E.S.T.ยฎ Contact Lens Study
NCT06878118Myopia, Myopia Progression
nthalmic Pty Ltd
Not applicable
80
Wenzhou
2025-07-06
Not yet open
A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China
NCT07042113Atopic Dermatitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
180
Wenzhou, Shanghai
2025-07
By invitation
Explainable Machine Learning for Predicting Early Gastric Cancer
NCT07047937Early Gastric Cancer
Wenzhou Central Hospital
Observational
10
Wenzhou
2025-06-28
Not yet open
Effect of Sevoflurane on Sweat Threshold in Children of Different Ages
NCT07035782Child, Only, Temperature Regulation; Disorder, Low Body Temperatures, Sevoflurane
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2025-06
Recruiting
Effect of Vitamin A Supplementation on Idiopathic Scoliosis
NCT07335991Vitamin A Deficiency, Idiopathic Scoliosis
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
140
Wenzhou
2025-05-13
Active, closed
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
NCT06934044Multiple Myeloma
Hoffmann-La Roche
Phase 1
20
Guangzhou, Tianjin, Nanchang, Wenzhou, Wuhan
2025-05-13
Recruiting
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NCT06947356Hepatitis B
Guangzhou 8th People's Hospital
Not applicable
210
Guangzhou, Shenzhen, Shijiazhuang, Changsha, Wenzhou, Beijing
2025-05-03
Not yet open
Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery
NCT06943690Rectal Cancer, Surgery
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Recruiting
A Phase โ…กa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
NCT06474442Herpes Simplex Virus Type I Stromal Keratitis
Shanghai BDgene Co., Ltd.
Phase 2
40
Wenzhou
2025-04-28
Recruiting
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
NCT06842524Polycystic Ovary Syndrome (PCOS)
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
Not yet open
A Clinical Study on the Feasibility and Safety of Abdominal Endoscopic Single-port Surgery System to Assist Gynecological Day Surgery
NCT06828419Adenopathy, Uterine Fibroids, Ovarian Cysts, Adnexal Mass
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
63
Wenzhou
2025-04-10
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
Icaritin in Combination With AG in Patients With Previously Untreated Advanced Pancreatic Ductal Adenocarcinoma
NCT06825546Advanced Pancreatic Ductal Adenocarcinoma
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Recruiting
Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial
NCT06932328Acute Pharyngitis
Jianmin Pharmaceutical Group Co., LTD.
Phase 2
216
Harbin, Changsha, Changchun, Jinan, Luzhou, Tianjin, Wenzhou
2025-03-26
Recruiting
Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients
NCT06948357Presbyopia
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Phase 2
119
Wenzhou
2025-03-24
Recruiting
Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia
NCT06853431Preoperative Anxiety, Preoperative Sedation, Children, Dexmedetomidine
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
80
Wenzhou
2025-03-01
Recruiting
Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID)
NCT06984549Dry Eye Disease (DED)
Chen Wei
Observational
150
Wenzhou
2025-03-01
Recruiting
Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D
NCT06745778Ventricular Tachycardia (VT), Ventricular Fibrillation
Medtronic Cardiac Rhythm and Heart Failure
Observational
50
Wenzhou, Shanghai
2025-02-26
Recruiting
AI-Assisted Medical Decision-Making
NCT06846229Real-world Study
The Eye Hospital of Wenzhou Medical University
Observational
50,000,000
Wenzhou
2025-02-24
By invitation
Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
NCT06902792Histiocytosis, Langerhans-Cell
Second Affiliated Hospital of Wenzhou Medical University
Phase 1
6
Wenzhou
2025-02-06
Not yet open
Effect of Propofol Versus Remimazolam Intravenous Anesthesia on Respiratory Depression
NCT06816173Respiratory Depression
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
96
Wenzhou
2025-02
Recruiting
AI-Driven Cancer Diagnosis and Prediction With EHR
NCT06791473Tumor
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Chengdu, Wenzhou
2025-01-19
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
Effect of Lactobacillus DSM17938+ on Functional Constipation and Intestinal Flora in Pregnant Women
NCT06802042Functional Constipation (FC)
Peking Union Medical College Hospital
Not applicable
40
Beijing, Wenzhou
2025-01-09
Recruiting
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
NCT06722586Antiphospholipid (aPL)-Positive, Thrombocytopaenia
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, รœrรผmqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
NCT06375005Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Active, closed
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT06743646Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
Chigenovo Co., Ltd
Phase 3
62
Beijing, Guangzhou, Haerbin, Zhengzhou, Shanghai, Chengdu, Tianjin, Wenzhou
2024-12-27
Not yet open
Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease
NCT06739278Crohn Disease
Second Affiliated Hospital of Wenzhou Medical University
Observational
119
Wenzhou
2024-12-20
Recruiting
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190Ocular Diseases
The Eye Hospital of Wenzhou Medical University
Observational
5,000,000
Zhuhai, Wenzhou
2024-12-20
Active, closed
Using Psychophysics Methods to Investigate Sensory Dominance After Cataract Surgery
NCT06751342Cataract
Wenzhou Medical University
Observational
96
Wenzhou
2024-12-01
Recruiting
Ophthalmic AI-Assisted Medical Decision-Making
NCT06755060Ocular Diseases
The Eye Hospital of Wenzhou Medical University
Not applicable
100,000
Zhuhai, Wenzhou
2024-12-01
Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06634589B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Rows per page Showing 1–100 of 184
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/wenzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 184 of those studies with a site in Wenzhou.

How many clinical trials are recruiting in Wenzhou?

110 of the 184 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 37 have not yet opened recruitment, 30 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wenzhou), 184 studies
PhaseStudiesRecruitingShare
Observational493626.6%
Not applicable401921.7%
Phase 3291215.8%
Phase 2251813.6%
Phase 11799.2%
Phase 41075.4%
Phase 1/2874.3%
Phase EARLY_PHASE1512.7%
Phase 2/3110.5%

Most active sponsors

Lead sponsors with the most studies (Wenzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital of Wenzhou Medical University3218
First Affiliated Hospital of Wenzhou Medical University2713
The Eye Hospital of Wenzhou Medical University99
Janssen Research & Development, LLC53
Wenzhou Medical University53
Alexion Pharmaceuticals, Inc.41
Eli Lilly and Company43
First Affiliated Hospital of Zhejiang University43
Novartis Pharmaceuticals42
Second Affiliated Hospital, Zhejiang University, School of Medicine42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.